drug discovery

Since 2015, a research team led by Northeastern engineering professor Carol Livermore has used origami to develop tissues that mimic tissues in the human body. Photo by Adam Glanzman/Northeastern University

How one Northeastern spinoff is using origami to speed up drug development

To engineering professor Carol Livermore, origami is more than just beautiful art—it’s a platform to create life-saving innovations in science and medicine.

by Sarah Coppola February 7, 2018

Northeastern's Slava Epstein developed a device called the iChip that permits researchers to tap into the untold number of microorganisms that won’t grow in the lab. Photo by Mary Knox Merrill/Northeastern University

Researcher develops technology to advance antibiotic discovery

Tonight, Northeastern’s Slava Epstein will give a talk following the screening of the short documentary The History of Resistance on his contributions to the search for beneficial microorganisms in places as close to home as his own backyard and, perhaps one day, as remote as the planet Mars.

by Thea Singer March 21, 2017

09/09/15 - BOSTON, MA. - Guohao Dai, associate professor in the Department of Bioengineering poses for a portrait in West Village H at Northeastern University on Sept. 9, 2016. In his research, he's pioneered the development of 3-D bioprinting technology to create tissue cultures for use in human disease modeling and drug discovery. Photo by: Matthew Modoono/Northeastern University

New professor uses 3-D bioprinting to explore vascular disease

Nowadays, 3-D printed objects are ubiquitous, from toys to office supplies to coffee mugs. But new Northeastern faculty member Guohao Dai is pioneering this technology to bring bioengineering solutions to challenges in vascular biology. Specifically, he’s 3-D bioprinting live tissue.

by Greg St. Martin November 17, 2016

09/08/15 - BOSTON, MA. - Diomedes Logothetis is a the new professor and chair, Department of Pharmaceutical Sciences. His research focuses on elucidating intracellular as well as cell-to-cell signaling mechanisms. Photo by: Matthew Modoono/Northeastern University

Advancing Northeastern’s leadership in drug discovery

Diomedes Logothetis, the new chair of the Department of Pharmaceutical Sciences, has a vision: To advance Northeastern’s standing as a go-to institution for academic researchers interested in drug discovery. “We can be the engine driving the understanding of how new drugs act,” he says.

by Thea Singer September 28, 2016

Using biology to engineer better therapeutics

New chemical engineering professor Debra Auguste studies human biology at the cellular level with an eye toward identifying more effective drug delivery therapies.

by Joe O'Connell September 12, 2016

December 23, 2014 - Kim Lewis, University Distinguished Professor and Director of the Antimicrobial Discovery Center in the College of Science, researches novel antibiotic treatments.

Northeastern receives $9M grant to fast track the discovery of new antibiotics

A team led by University Distinguished Professor of Biology Kim Lewis received a five-year, $9 million grant from the National Institute of Health’s National Institute of Allergy and Infectious Diseases to launch a novel platform for developing antibiotics that kill pathogens without encountering resistance.

by Thea Singer July 11, 2016

Drug discovery and delivery research at Northeastern’s pharmacy school spurs innovation, collaboration

Throughout Northeastern’s School of Pharmacy, researchers are making progress in solving a range of pressing health challenges.

by Greg St. Martin November 12, 2015

Graduate researcher wins fellowship to design drugs to combat deadly disease

Chemistry doctoral student Dana Klug makes possible drug options the way a chef makes a gourmet dish—adding an atom of hydrogen here, removing an atom of nitrogen there—to stop a deadly parasite in its tracks.

by Thea Singer August 31, 2015

Groundbreaking Northeastern research sweeps the globe

Northeastern University Distinguished Professor Kim Lewis and his team’s pioneering research presenting a new antibiotic that kills pathogens without encountering any detectable resistance has captured headlines worldwide and drawn widespread praise from the scientific community.

by Greg St. Martin January 9, 2015

New grant to advance sleeping sickness treatment research

Associate professor of chemistry and chemical biology Michael Pollastri has received a five-year, $2.5 million grant from the National Institutes of Health to advance his research into a treatment for sleeping sickness.

by Joe O'Connell December 11, 2014